Minn. Stat. § 245D.051: Psychotropic Medication Use and Monitoring

2026 edition · Last amended 2022 ·

In plain language

This section governs how a disability services provider handles psychotropic medications when it is responsible for giving them. The provider must document the target symptoms the medication is meant to relieve and, if the prescriber requires it, track and report data on the medication and those symptoms, giving the monitoring data to the support team every three months or when the person or their legal representative asks. If the person or their legal representative refuses to authorize a psychotropic medication, the provider must not give it, must report the refusal to the prescriber, and must follow the prescriber's directions. A refusal cannot be overridden without a court order and is not grounds for ending services.

Where this summary and the official text differ, the official text controls.

What this means for you

If you or your family member receives disability services and takes a psychotropic medication that the provider gives, the provider must write down what symptoms the medication targets and may have to monitor and report on how it is working, sharing that data with your support team at least every three months. You or your legal representative have the right to refuse a psychotropic medication: the provider cannot give it over your refusal, and that refusal cannot be overridden without a court order and cannot be used as a reason to terminate your services.

Text of the law

Subdivision 1. Conditions for psychotropic medication administration.

(a) When a person is prescribed a psychotropic medication and the license holder is assigned responsibility for administration of the medication in the person’s support plan or the support plan addendum, the license holder must ensure that the requirements in section 245D.05, subdivision 2, are met.

(b) The license holder must develop, implement, and maintain the following documentation in the person’s support plan addendum according to the requirements in sections 245D.07 and 245D.071:

(1) a description of the target symptoms that the psychotropic medication is to alleviate; and

(2) documentation methods the license holder will use to monitor and measure changes in the target symptoms that are to be alleviated by the psychotropic medication if required by the prescriber. The license holder must collect and report on medication and symptom-related data as instructed by the prescriber. The license holder must provide the monitoring data to the expanded support team for review every three months, or as otherwise requested by the person or the person’s legal representative.

For the purposes of this section, “target symptom” refers to any perceptible diagnostic criteria for a person’s diagnosed mental disorder, as defined by the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision (DSM-IV-TR) or successive editions, that has been identified for alleviation.

Subd. 2. Refusal to authorize psychotropic medication.

If the person or the person’s legal representative refuses to authorize the administration of a psychotropic medication as ordered by the prescriber, the license holder must not administer the medication. The refusal to authorize medication administration must be reported to the prescriber as expediently as possible. After reporting the refusal to the prescriber, the license holder must follow any directives or orders given by the prescriber. A refusal may not be overridden without a court order. Refusal to authorize administration of a specific psychotropic medication is not grounds for service termination and does not constitute an emergency. A decision to terminate services must be reached in compliance with section 245D.10, subdivision 3.

History: 2013 c 108 art 8 s 26; 2014 c 275 art 1 s 50,140; 2014 c 312 art 27 s 30; 2022 c 98 art 17 s 26